Revised July 1, 2026
     Continuous Antimicrobial Technology "AbedulAg+" for Infection Prevention

                   ～Scientific Validation and Exploration of Technical Possibilities～

How to Confront Infections Caused by Drug-Resistant Bacteria?

            Please enter from "How to Combat Infections Caused by Drug-Resistant Bacteria?"

                                    at the top of the homepage. You can view the details there.

Table of Contents

Infectious Diseases Are a Persistent Global Challenge.

 Infectious Diseases Are a Persistent Global Challenge.​

  1,  Why Did We Choose Textiles as Our Primary Target?
  2,  Why Should We Focus on Antimicrobial-Resistant Pathogens?

  3,  Current Status of Infections Caused by Antimicrobial-Resistant Pathogens.
  4,  Why Are Infectious Diseases Considered a Perpetual Challenge for Humanity?

  5,  A New Paradigm in Infection Prevention Introduced by the U.S. EPA's 2008 Registration of Copper

       Alloys.

  6,  Advantages of Using Electrolytically Generated Silver Ions as the Active Antimicrobial Species.

  7,  Advantages of the Antimicrobial Mechanism of Silver Ions.

  8,  Advantages of Silver Ion Antimicrobial Technology in Terms of Safety.

  9,  Economic Advantages of Silver Ion Antimicrobial Technology.

10,  Demonstration of Sustained Bactericidal Efficacy (Submitted on August 5, 2026)

​

Presentation materials for business partners

                                                                                       (Posted on August 10, 2026)

​